Assura Group Limited
07 March 2008
Assura Group Limited ('Assura' or the 'Company')
Director Change
and
Proposed Changes to the Investment Policy and Memorandum of Association
Director Change
Assura Group Limited announces that Dr Mark Jackson, its Non-executive Chairman,
has decided to step down from its Board and as Non-executive Chairman with
immediate effect.
The Board recognises that Dr Jackson has increasing commitments as Chief
Executive of Helphire Group PLC and would like to record their thanks for his
hard work and commitment to Assura since its flotation in 2003.
Assura announces that, with immediate effect, Dr John Curran, presently the
Board's senior independent Director and a Non-executive member of the Board will
assume the role as Interim Chairman of the Board.
The Company is already advanced in the process of recruitment of a new
Non-executive Chairman and an announcement in relation to this is likely to be
made, once all necessary formalities are dealt with, in the near future.
Proposed Changes to the Investment Policy and Memorandum of Association
Assura proposes to make certain changes to the Company's investment policy and
its memorandum of association in order to align them with the Group's
activities, which have evolved significantly since the Company was established
as a closed-ended investment company in 2003. The Directors also propose to
make an application to the UK Listing Authority for the reclassification of the
Company from being a property investment company to being a trading company.
Assura will remain listed on the Main Market of the London Stock Exchange.
The Company will, today, post a circular to shareholders providing details of
these proposals and convening an extraordinary general meeting which will be
held at 9.00 a.m. on 3 April 2008 at which the approval of shareholders for
these changes will be sought.
In view of these proposals the Board is currently actively considering the
potential advantages and disadvantages of moving the location of the Company's
central management and control from Guernsey to the UK which would result in the
Company becoming resident in the UK for UK tax purposes. No decision on this
will be taken before 1 April 2008 and an announcement will be made if the Board
does decide to make any change.
Ends
Notes to Editors:
Dr Jackson was appointed non-executive chairman of Assura Group Limited in
November 2003.
Dr John Curran joined the Board of Assura Group Limited in November 2003 and has
been throughout his tenure on the Board the non-executive deputy chairman and
senior independent director.
Enquiries:
Richard Burrell/Louise Bathersby: Assura Group 020 7107 3800
David Yates / Ben Atwell: Financial Dynamics 020 7831 3113
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.